Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.
Interleukin-1beta promotes repair of the CNS.
Immunology 2015
An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.
Episode 30 with Dr. Seema Tiwari-Woodruff on estrogenic compounds and MS
A study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis (TENERE)
MS Frontiers 2015
Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
Webinar: "Seeking Best Practices in Classifier Construction and Testing"
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.
ForuMS: A Virtual Journal Club for MS Clinicians
Episode 8 with Dr. Wendy Macklin on myelination and the zebrafish model of MS
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients.
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
Episode 31 with Dr. Lloyd Kasper on the gut microbiome and MS
Neuroprotective effects of resident microglia following acute brain injury.
Brain reserve against physical disability progression over 5 years in multiple sclerosis.
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
Episode 10 with Dr. Richard Ransohoff on his group's latest research
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.
Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.

Pages